UK's Ofwat and Nesta Challenges have called on pharmaceutical innovators to collaborate with water companies for the new Water Breakthrough Challenge.
Ofwat, a non-ministerial government department of the United Kingdom, and Nesta Challenges, part of the Nesta innovation foundation, have called on pharmaceutical innovators to collaborate with water companies for the new Water Breakthrough Challenge.
According to a March 25, 2021 press release, the £40 million (US $55 million) is being funded through Ofwat’s Innovation Fund, as part of the regulator’s goal to create an innovative and collaborative water sector that meets the needs of customers, society, and the environment. Through encouraging collaborations, the challenge aims to tackle the biggest obstacles facing water and wastewater services.
Entries are to be submitted by water companies in England and Wales, but partnerships with organizations outside the water sector, such as pharmaceuticals, are allowed. The open date for entries is May 6, 2021, and successful partnerships will have a chance to win up to £10 million (US $13.8 million).
“This competition follows on from the successful Innovation in Water Challenge that we ran earlier this year, when we received dozens of brilliant entries,” said John Russell, senior director at Ofwat, in the press release. “We now want to build on this momentum by encouraging and developing new partnerships and even bigger innovative projects that could make a real and lasting difference to the environment, society, and people’s lives—now and well into the future.”
“Climate change, extreme weather, and aging infrastructure are among the major challenges facing the water sector. Rising to these challenges demands that the sector goes beyond its business as usual, by seeking out, testing, and scaling up new solutions, new ways of working, and novel partnerships,” added Chris Gorst, director of Challenges at Nesta Challenges, in the press release. “With this Challenge we hope to pump-prime this process and to uncover and support truly breakthrough innovations that will deliver tangible benefits to water customers, wider society, and the environment.”
Source: Ofwat
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Understanding the Variability in Bioburden Test Results in Biomanufacturing
May 7th 2025This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Intertek to Expand UK GMP Facility with 6000 Square Feet of Lab and Office Space
May 7th 2025The company said the expansion is in response to globally rising demand for inhaled biologics, which offer distinct advantages in route of administration, but can be challenging products for developers.